Reply: Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic

Abstract

Get full access to this article

View all access options for this article.

References

, Joe

, Jung

, Kim

. Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain. Clin Neuropharmacol 2005;28:169-75.

Afshar

, Roohafza

, Mousavi

. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial. J Psychopharmacol 2009;23:157-62. DOI 10.1177/0269881108089816

Tiihonen

, Halonen

, Wahlbeck

. Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial. J Clin Psychiatry 2005;66:1012-5.

Deutsch

, Schwartz

, Rosse

, Mastropaolo

, Marvel

, Drapalski

. Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia. Clin Neuropharmacol 2003;26:199-206.

Narula

, Rehan

, Unni

, Gupta

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial. Schizophr Res 2010. DOI 10.1016/j.schres.2010.02.001

Reply: Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic–Induced Weight Gain

Abstract

Get full access to this article

References